Genomind

Developer of genetic tests for personalised medicines to enhance mental health treatment

placeKing Of Prussia, Pennsylvania, United States calendar_todayFounded 2009 groups65 employees language genomind.com

Registered entities

Investor mix

3 investors on record; lead investors include SVB, Claritas Capital.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon